Showing results (271-280 of 332) with videos related to
Sort By:
Pageof 34
United European Gastroenterology Journal|October 13, 2025
Disease Monitoring in Inflammatory Bowel Disease Daily Clinical Practice and Impact on Treatment Decision Making: Real World Evidence From the Inflammatory Bowel Disease-PODCAST StudyAxel Dignass, Fernando Magro, Ferdinando D'Amico, et al.Inflammatory Bowel Diseases|February 25, 2009
Crohn's disease in a southern European country: Montreal classification and clinical activityFernando Magro, Francisco Portela, Paula Lago, et al.Journal of Crohn'S & Colitis|May 20, 2026
Time to rethink washout periods in inflammatory bowel disease clinical trials: an international Delphi consensusPauline Wils, Vipul Jairath, Bruce E Sands, et al.Therapeutic Advances in Gastroenterology|September 14, 2019
Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumabFernando Magro, Susana Lopes, Marco Silva, et al.Virchows Archiv : an International Journal of Pathology|February 4, 2014
The histopathological approach to inflammatory bowel disease: a practice guideCord Langner, Fernando Magro, Ann Driessen, et al.The American Journal of Gastroenterology|May 1, 2026
Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week 92 of the QUASAR Long-Term Extension StudyGary R Lichtenstein, Jessica R Allegretti, David T Rubin, et al.Scandinavian Journal of Gastroenterology|June 30, 2025
External multicenter validation of the FAMISH score for predicting metachronous gastric lesions after endoscopic submucosal dissectionMónica Garrido, Tatiana Cruz Almeida, Ricardo Kuttner-Magalhães, et al.Journal of Crohn'S & Colitis|May 27, 2016
Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving InfliximabFernando Magro, Susana Isabel Lopes, Joanne Lopes, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2023
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximabPaula Sousa, Marta Patita, Bruno Arroja, et al.Inflammatory Bowel Diseases|October 14, 2009
Ulcerative colitis in a Southern European country: a national perspectiveFrancisco Portela, Fernando Magro, Paula Lago, et al.Pageof 34